SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India trades jubilantly on plan of investing $84 million for expansion

21 Feb 2017 Evaluate

Granules India is currently trading at Rs. 131.45, up by 6.10 points or 4.87% from its previous closing of Rs. 125.35 on the BSE.

The scrip opened at Rs. 126.70 and has touched a high and low of Rs. 132.40 and Rs. 126.25 respectively. So far 216372 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 151.15 on 14-Jul-2016 and a 52 week low of Rs. 91.45 on 09-Nov-2016.

Last one week high and low of the scrip stood at Rs. 132.40 and Rs. 121.10 respectively. The current market cap of the company is Rs. 2903.50 crore.

The promoters holding in the company stood at 51.88%, while institutions and non-institutions held 7.24% and 40.88% respectively.

Granules India, one of the leading drug makers in India, is reportedly planning to invest $84 million in setting up new capacities, expanding existing ones and investing in R&D to improve its product mix in favour of higher value-added products. The project cost is proposed to be financed with debt of $68.5 million, including a corporate loan of up to $47.5 million from International Finance Corporation (IFC), and the rest through equity and internal accruals.

Granules India is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs).

Granules India Share Price

662.55 8.15 (1.25%)
20-Apr-2026 09:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1677.45
Dr. Reddys Lab 1234.80
Cipla 1241.25
Zydus Lifesciences 948.10
Lupin 2332.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×